Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment — Aristotle Bamias (2007) | RDL Network
Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment
Article 2007 en
Authors
AB
Aristotle Bamias
GL
G. Lainakis
EK
Efstathios Kastritis
Abstract
1 min read
First-line gemcitabine/carboplatin combination is active in unfit-for-cisplatin patients with advanced urothelial carcinoma. Pretreatment quality of life and geriatric assessment may be useful in selecting patients likely to benefit from this treatment.
Aristotle Bamias, Lia A. Moulopoulos, Aggelos Koutras, Gerasimos Aravantinos, George Fountzilas, D. Pectasides, Efstathios Kastritis, D. Gika, Dimosthenis Skarlos, Helena Linardou, Haralabos P. Kalofonos, Meletios A Dimopoulos
Aristotelis Bamias, Efstathios Kastritis, George Bozas, Vassiliki Koutsoukou, N. Antoniou, H. Katsifotis, K. Konstantinidis, Andreas Skolarikos, C. Deliveliotis, Meletios A Dimopoulos
Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis, S. Kakolyris, Meletios A Dimopoulos, E. Papadakis, Demosthenes Bouros, F Apostolopoulou, Christos Papadimitriou, Athina Agelidou, Kostas Hatzakis, Kostas Kalbakis, Αthanasios Kotsakis, N. Vardakis, J. Vlachonicolis
Discussion(0)
No comments yet. Be the first to comment.